Clinical trials recruiting for Parkinson Disease (PD)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Adaptive DBS for PD
  NCT07635823 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs
  NCT07221266 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
  NCT07166757 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
  NCT07281794 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease
  NCT07810296 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
  NCT07312110 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 11 locations
• Daily Amino Acid Supplementation for People With Parkinson's Disease
  NCT07115563 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 90 Years · Sex: All (male and female) · 2 locations
• Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients
  NCT07619560 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 85 Years · Sex: All (male and female) · 1 location
• Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
  NCT07721688 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
  NCT07083089 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 4 locations
• Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
  NCT07536542 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 65 Years · Sex: All (male and female) · 1 location
• Effects of Transcranial Direct Current Stimulation Combined With Nordic Walking on Gait and Balance in Parkinson's Disease
  NCT07381907 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study
  NCT06928519 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
  NCT07097298 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Exercise Management in Parkinson's Disease
  NCT07302386 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · 1 location
• GBPDC: Gut-Brain in PD Consortium Master Protocol
  NCT07567794 · Phase: Not specified · Ages: 21 Years to 80 Years · Sex: All (male and female) · 7 locations
• L-THEANINE AND MEDITERRANEAN DIET ON RBD, GI FUNCTION, AND INFLAMMATION IN PARKINSON'S DISEASE
  NCT07682532 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Motor and Cognitive Exercise in Parkinson's Disease.
  NCT07465107 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
  NCT07281755 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease
  NCT07299240 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• Robot-Assisted Gait Training vs NMES in Parkinson's Disease
  NCT07589296 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease
  NCT06602544 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · 2 locations
• Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
  NCT07572071 · Phase: Phase 1 · Ages: 30 Years to 70 Years · Sex: All (male and female) · 3 locations
• Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
  NCT07284823 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · 2 locations
• Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
  NCT05395624 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 9 locations
• Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations
  NCT07761936 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Steps Against the Burden of Parkinson's Disease
  NCT07057219 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase
  NCT07640542 · Phase: Early Phase 1 · Ages: 50 Years to 75 Years · Sex: All (male and female) · 1 location
• Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
  NCT07157345 · Phase: Phase 1 · Ages: 40 Years to 65 Years · Sex: All (male and female) · 1 location
• The Effect of Bottle PEP Exercise on Expiratory Muscle Thickness, Strength, and Balance Parameters in Parkinson's Disease Patients
  NCT07680725 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength
  NCT07308795 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
  NCT07725562 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
  NCT06941012 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations

Related conditions

Trials recruiting for Parkinson Disease (PD) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Parkinson Disease (PD) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.